FDA Recalls Crocodile Bile Pills Marketed as Unapproved Asthma Drug
Murray International Trading Co. is recalling Crocodile Bile Pills for Asthma because they are marketed as dietary supplements but contain drug claims, making them unapproved drugs.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, which corresponds to a Severe severity score per the rubric, as it involves a product marketed without an approved NDA/ANDA.
Plain-English summary
Murray International Trading Co., Inc. is recalling Crocodile Bile Pills for Asthma. The product is packaged in 100-count bottles within a box, and the remaining labeling contains Chinese characters. The recall involves 48 bottles and covers all lots.
The FDA is recalling this product because it is marketed as a dietary supplement but has labeling that bears drug and disease claims. This makes the product an unapproved drug, as it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The product was distributed nationwide and in Puerto Rico. Consumers who have this product should stop using it and contact the recalling firm for instructions on how to return it or dispose of it safely.
The recalled product
- Product
- CROCODILE BILE PILL FOR ASTHMA, packaged in 100-count bottles within a box, remaining labeling contains Chinese characters.
- Manufacturer
- Murray International Trading Co., Inc.
- Category
- Drug — Unapproved Drug
- Hazard
- Affected units
- 48
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Part of a larger recall action
This product is one of 14 recalled by Murray International Trading Co., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Murray International Trading Co., Inc.
See all →- HighHerbal Doctor Angelicae Sinensis Recalled for Elevated Lead and Cadmium
FDA (Food) · 2021-12-08
- ModerateGastrodia Capsules Recalled for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- ModerateMurray International Trading Recalls Farser Kai Yeung Pill for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- SevereFUCONPO Capsule Recalled for Marketing Without Approved NDA or ANDA
FDA (Drugs) · 2016-07-20
- ModerateMurray International Recalls Unapproved Flucinonide Ointment Cream
FDA (Drugs) · 2016-07-20
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04